Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038

Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

Slamon, D. J., Godolphin, W. J., Jones, L. A., Holt, J. A., Wong, S., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J. A., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,817

Real-time quantification of microRNAs by stem-loop RT-PCR

Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,989

Exploring the metabolic and genetic control of gene expression on a genomic scale.

Derisi, J., Iyer, V., & Brown, P. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,832

NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317

miRBase: microRNA sequences, targets and gene nomenclature

Griffiths-Jones, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj112 · Cited by 3,950

A microRNA polycistron as a potential human oncogene

He, L., Thomson, J. M., Hemann, M. T., Hernando, E., Mu, D., Goodson, S. G., Powers, S., Cordon‐Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,642

MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer

Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605

MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells

Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557

MicroRNAs in Development and Disease

Sayed, D. H., & Abdellatif, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00006.2010 · Cited by 1,101

miRNAs in human cancer

Farazi, T. A., Spitzer, J., Morozov, P. S., & Tuschl, T. (2010) · The Journal of Pathology · doi:10.1002/path.2806 · Cited by 900

MicroRNAs in Human Cancer

Farazi, T. A., Hoell, J. I., Morozov, P. S., & Tuschl, T. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-5590-1_1 · Cited by 709

Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21

Hatley, M. E., Patrick, D. M., Garcia, M. R., Richardson, J. A., Bassel-Duby, R., van Rooij, E., & Olson, E. N. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.013 · Cited by 626

Plasma exosome microRNAs are indicative of breast cancer

Hannafon, B. N., Trigoso, Y. D., Calloway, C. L., Zhao, Y. D., Lum, D. H., Welm, A. L., Zhao, Z. J., Blick, K. E., Dooley, W. C., & Ding, W. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0753-x · Cited by 603

The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics

Bautista-Sánchez, D., Arriaga-Canon, C., Pedroza-Torres, A., De La Rosa-Velázquez, I. A., González-Barrios, R., Contreras-Espinosa, L., Montiel-Manríquez, R., Castro-Hernández, C., Fragoso-Ontiveros, V., Álvarez-Gómez, R. M., et al. (2020) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2020.03.003 · Cited by 549

Negative regulation of lncRNA GAS5 by miR-21

Zhang, Z., Zhu, Z., Watabe, K., Zhang, X., Bai, C., Xu, M., Wu, F., & Mo, Y.-Y. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.110 · Cited by 419

Apoptosis and the target genes of microRNA-21

Buscaglia, L. E. B., & Li, Y. (2011) · 癌症：英文版 · doi:10.5732/cjc.011.10132 · Cited by 383

MicroRNAs in idiopathic pulmonary fibrosis

Pandit, K. V., Milošević, J., & Kaminski, N. (2011) · Translational research · doi:10.1016/j.trsl.2011.01.012 · Cited by 316

Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer

Gong, C., Yao, Y., Wang, Y., Liu, B., Wu, W. G., Chen, J., Su, F., Yao, H., & Song, E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.216887 · Cited by 313

The role of microRNAs in endometriosis and associated reproductive conditions

Ohlsson Teague, E. M. C., Print, C. G., & Hull, M. L. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp034 · Cited by 309

Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management

van Schooneveld, E., Wildiers, H. P. M. W., Vergote, I. B., Vermeulen, P. B., Dirix, L. Y., & Laere, S. V. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0526-y · Cited by 297

Biosensors for breast cancer diagnosis: A review of bioreceptors, biotransducers and signal amplification strategies

Mittal, S., Kaur, H., Gautam, N., & Mantha, A. K. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.08.028 · Cited by 295

MicroRNA control of epithelial–mesenchymal transition and metastasis

Zhang, J., & Ma, L. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9368-6 · Cited by 273

MicroRNAs in cancer — from research to therapy

Cho, W. C. S. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.11.003 · Cited by 234

Intracellular and Extracellular MicroRNAs in Breast Cancer

Corcoran, C., Friel, A. M., Duffy, M. J., Crown, J. P., & O’Driscoll, L. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.150730 · Cited by 231

MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer

Andorfer, C. A., Necela, B. M., Thompson, E. A., & Perez, E. A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.006 · Cited by 213

Micro RNA s play a central role in molecular dysfunctions linking inflammation with cancer

Tili, E., Michaille, J., & Croce, C. M. (2013) · Immunological Reviews · doi:10.1111/imr.12050 · Cited by 211

Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases

Aitken, S. J., Thomas, J. S. J., Langdon, S. P., Harrison, D. J., & Faratian, D. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp427 · Cited by 187

MicroRNAs in regulation of triple-negative breast cancer progression

Piasecka, D., Braun, M., Kordek, R., Sądej, R., & Romańska, H. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2689-2 · Cited by 193

Metastamirs: a stepping stone towards improved cancer management

White, N. M. A., Fatoohi, E., Metias, M., Jung, K., Stephan, C., & Yousef, G. M. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.173 · Cited by 184

Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy

Martínez, A. R., de Miguel‐Pérez, D., Ortega, F. G., García-Puche, J. L., Robles‐Fernandez, I., Expósito, J., Martorell‐Marugán, J., Carmona‐Sáez, P., Garrido-Navas, M. C., Rolfo, C. D., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1109-0 · Cited by 180

MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation

Li, Q., Zhang, D., Wang, Y., Sun, P., Hou, X., Larner, J., Xiong, W., & Mi, J. (2013) · Scientific Reports · doi:10.1038/srep02038 · Cited by 179

Regulation of microRNAs in cancer metastasis

Bouyssou, J., Manier, S., Huynh, D., Issa, S., Roccaro, A. M., & Ghobrial, I. M. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.02.002 · Cited by 176

Prooncogenic Factors miR-23b and miR-27b Are Regulated by Her2/ Neu , EGF, and TNF-α in Breast Cancer

Jin, L., Wessely, O., Marcusson, E. G., Ivan, C., Călin, G. A., & Alahari, S. K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2162 · Cited by 176

MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs

Aigner, A. M. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0716-0 · Cited by 147

Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease

Wancket, L. M., Frazier, W. J., & Liu, Y. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.11.017 · Cited by 137

MiR‐21 regulates epithelial‐mesenchymal transition phenotype and hypoxia‐inducible factor‐1α expression in third‐sphere forming breast cancer stem cell‐like cells

Han, M., Wang, Y., Liu, M., Bi, X., Bao, J., Zeng, N., Zhu, Z.-K., Mo, Z., Wu, C., & Chen, X. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02281.x · Cited by 131

Heterogeneous Nuclear Ribonucleoprotein C1/C2 Controls the Metastatic Potential of Glioblastoma by Regulating PDCD4

Park, Y. M., Hwang, S. J., Masuda, K., Choi, K.-M., Jeong, M., Nam, D., Gorospe, M., & Kim, H. H. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00443-12 · Cited by 126

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

Aktas, B., Müller, V., Tewes, M., Zeitz, J., Kasimir‐Bauer, S., Loehberg, C. R., Rack, B. K., Schneeweiß, A., & Fehm, T. N. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.04.039 · Cited by 124

Magnetobiosensors Based on Viral Protein p19 for MicroRNA Determination in Cancer Cells and Tissues

Campuzano, S., Torrente-Rodríguez, R. M., López‐Hernández, E., Conzuelo, F., Granados, R., Sánchez-Puelles, J.-M., & Pingarrón, J. M. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403270 · Cited by 119

Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells

Ming-li, H., Liu, M., Wang, Y., Mo, Z., Bi, X., Liu, Z., Fan, Y., Chen, X., & Wu, C. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1195-5 · Cited by 115

The roles of oncogenic miRNAs and their therapeutic importance in breast cancer

O’Bryan, S. M., Dong, S., Mathis, J. M., & Alahari, S. K. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.11.004 · Cited by 117

MicroRNA regulation of innate immune responses in epithelial cells

Zhou, R., O’Hara, S. P., & Chen, X. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2011.19 · Cited by 111

MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features

Lee, H.-J., Park, C. S., Deftereos, G., Morihara, J. K., Stern, J., Hawes, S. E., Swisher, E. M., Kiviat, N. B., & Feng, Q. (2012) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-10-174 · Cited by 109

Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis

Shi, M., Liu, D., Duan, H., Shen, B., & Guo, N. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9265-9 · Cited by 108

MiR-21 Simultaneously Regulates ERK1 Signaling in HSC Activation and Hepatocyte EMT in Hepatic Fibrosis

Zhao, J., Tang, N., Wu, K., Dai, W., Ye, C., Shi, J. G., Zhang, J., Ning, B., Zeng, X. Y., & Lin, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108005 · Cited by 106

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development

Rivas, M. A., Venturutti, L., Huang, Y., Schillaci, R., Huang, T. H. ‐., & Elizalde, P. V. (2012) · Breast Cancer Research · doi:10.1186/bcr3187 · Cited by 106

Exosomes released from neural progenitor cells and induced neural progenitor cells regulate neurogenesis through miR-21a

Ma, Y., Li, C., Huang, Y., Wang, Y., Xia, X., & Zheng, J. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0418-3 · Cited by 105

Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation

Wang, X., Li, C., Ju, S., Wang, Y., Wang, H., & Zhong, R. (2011) · Leukemia & Lymphoma · doi:10.3109/10428194.2011.591004 · Cited by 103

miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2

Zhao, Q., Chen, S., Zhu, Z., Yu, L., Ren, Y., Jiang, M., Weng, J., & Li, B. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1182-9 · Cited by 109

MicroRNA-mediated breast cancer metastasis: from primary site to distant organs

Wang, L., & Wang, J. (2011) · Oncogene · doi:10.1038/onc.2011.444 · Cited by 102

MicroRNA-21 gene and cancer

Huang, Y., Yang, Y. B., Zhang, X. H., Yu, X. L., Wang, Z. B., & Cheng, X. C. (2012) · Medical Oncology · doi:10.1007/s12032-012-0376-8 · Cited by 102

High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation

Dong, G., Liang, X., Wang, D., Gao, H., Wang, L., Wang, L., Liu, J., & Du, Z. (2014) · Medical Oncology · doi:10.1007/s12032-014-0057-x · Cited by 100

Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer

Zhao, Y., Zhao, L., Ischenko, I., Bao, Q., Schwarz, B., Nieß, H., Wang, Y., Renner, A., Mysliwietz, J., Jauch, K., et al. (2015) · Targeted Oncology · doi:10.1007/s11523-015-0360-2 · Cited by 101

Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs

Loayza‐Puch, F., Yoshida, Y., Matsuzaki, T., Takahashi, C., Kitayama, H., & Noda, M. (2010) · Oncogene · doi:10.1038/onc.2010.23 · Cited by 97

Prognostic Significance of Metastasis-Related MicroRNAs in Early Breast Cancer Patients with a Long Follow-up

Markou, A. N., Yousef, G. M., Stathopoulos, E. N., Georgoulias, V., & Lianidou, E. S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.210542 · Cited by 96

β2-AR signaling controls trastuzumab resistance-dependent pathway

Liu, D., Yang, Z., Wang, T., Yang, Z., Chen, H., Hu, Y., Hu, C., Guo, L., Deng, Q., Liu, Y., et al. (2015) · Oncogene · doi:10.1038/onc.2015.58 · Cited by 95

miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer

Mathe, A., Scott, R. J., & Avery‐Kiejda, K. A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226090 · Cited by 97

Curcumin as tyrosine kinase inhibitor in cancer treatment

Golonko, A., Lewandowska, H., Świsłocka, R., Jasińska, U., Priebe, W., & Lewandowski, W. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.015 · Cited by 96

High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2+ Inflammatory Breast Cancer

Anfossi, S., Giordano, A., Gao, H., Cohen, E. N., Tin, S., Wu, Q., Garza, R. J., Debeb, B. G., Álvarez, R. H., Valero, V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083113 · Cited by 95

microRNAs in Cancer Cell Response to Ionizing Radiation

Czochor, J. R., & Glazer, P. M. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5718 · Cited by 90

Therapeutic Perspectives of Molecules from Urtica dioica Extracts for Cancer Treatment

Esposito, S., Bianco, A., Russo, R., Maro, A. D., Isernia, C., & Pedone, P. V. (2019) · Molecules · doi:10.3390/molecules24152753 · Cited by 89

MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1

Venturutti, L., Russo, R. I. C., Rivas, M. A., Mercogliano, M. F., Izzo, F., Oakley, R. H., Pereyra, M. G., Martino, M. D., Proietti, C. J., Yankilevich, P., et al. (2016) · Oncogene · doi:10.1038/onc.2016.151 · Cited by 86

The role of TGF-β1–miR-21–ROS pathway in bystander responses induced by irradiated non-small-cell lung cancer cells

Jiang, Y., Chen, X., Tian, W., Yin, X., Wang, J., & Yang, H. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.368 · Cited by 85

miRNAs and regulation of cell signaling

Ichimura, A., Ruike, Y., Terasawa, K., & Tsujimoto, G. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08087.x · Cited by 86

The role of oncomirs in the pathogenesis and treatment of breast cancer

Hemmatzadeh, M., Mohammadi, H., Jadidi‐Niaragh, F., Asghari, F., & Yousefi, M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.01.026 · Cited by 85

RNA Helicase DDX5 Regulates MicroRNA Expression and Contributes to Cytoskeletal Reorganization in Basal Breast Cancer Cells

Wang, D., Huang, J., & Hu, Z. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.011932 · Cited by 85

Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs

Velagapudi, S. P., Costales, M. G., Vummidi, B. R., Nakai, Y., Angelbello, A. J., Tran, T. A., Haniff, H. S., Matsumoto, Y., Wang, Z. F., Chatterjee, A. K., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.05.015 · Cited by 81

microRNAs in Gliomas: Small Regulators of a Big Problem

Silber, J., James, C. D., & Hodgson, J. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8087-9 · Cited by 80

Novel breast cancer screening: combined expression of miR-21 and MMP-1 in urinary exosomes detects 95% of breast cancer without metastasis

Ando, W., Kikuchi, K., Uematsu, T., Yokomori, H., Takaki, T., Sogabe, M., Kohgo, Y., Otori, K., Ishikawa, S., & Okazaki, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-50084-5 · Cited by 80

Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma

Ren, J., Zhu, D., Liu, M., Sun, Y., & Tian, L. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.047 · Cited by 79

MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases

Li, S., Liang, Z., Liu, X., & Zou, F. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1052-6 · Cited by 78

MiR-21 Is Required for the Epithelial–Mesenchymal Transition in MDA-MB-231 Breast Cancer Cells

Arısan, E. D., Rencüzoğulları, Ö., Cieza-Borrella, C., Miralles, F., Dwek, M. V., Lange, S., & Onganer, P. U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041557 · Cited by 74

Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma

Sun, S.-S., Zhou, X., Huang, Y.-Y., Kong, L.-P., Mei, M., Guo, W.-Y., Zhao, M.-H., Ren, Y., Shen, Q., & Zhang, L. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0487-x · Cited by 72

Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Sareyeldin, R. M., Gupta, I., Al‐Hashimi, I., Al-Thawadi, H., Farsi, H. F. A., Vranić, S., & Moustafa, A. A. (2019) · Cancers · doi:10.3390/cancers11050646 · Cited by 76

Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients

Toraih, E. A., Mohammed, E. A.-M., Farrag, S. H., Ramsis, N., & Hosny, S. (2015) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-015-0143-6 · Cited by 69

Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review

Ismail, A., El‐Mahdy, H. A., Abulsoud, A. I., Sallam, A.-A. M., Eldeib, M. G., Elsakka, E. G. E., Zaki, M. B., & Doghish, A. S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.241 · Cited by 67

Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis

Venturutti, L., Romero, L., Urtreger, A., Chervo, M., Russo, R., Mercogliano, M., Inurrigarro, G., Pereyra, M., Proietti, C., Izzo, F., et al. (2016) · Oncogene · doi:10.1038/onc.2015.281 · Cited by 65

miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development

Petrović, N. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0186-3 · Cited by 66

MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival

Mima, K., Nishihara, R., Yang, J., Dou, R., Masugi, Y., Shi, Y. X., da Silva, A., Cao, Y., Song, M., Nowak, J. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2173 · Cited by 65

MicroRNAs: Promising New Antiangiogenic Targets in Cancer

Gallach, S., Fariñas, S. C., Lewintre, E. J., & Camps, C. (2014) · BioMed Research International · doi:10.1155/2014/878450 · Cited by 64

ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy

Elizalde, P. V., Russo, R. I. C., Chervo, M. F., & Schillaci, R. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0360 · Cited by 68

TGF-β-induced miR-21 negatively regulates the antiproliferative activity but has no effect on EMT of TGF-β in HaCaT cells

Wang, T., Zhang, L., Shi, C., Sun, H., Wang, J., Li, R., Zou, Z., Ran, X., & Su, Y. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.11.012 · Cited by 62

MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype

Santarpia, L., Nicoloso, M. S., & Calin, G. A. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0222 · Cited by 63

The Role of MicroRNAs in Lung Cancer: Implications for Diagnosis and Therapy

Naeli, P., Yousefi, F., Ghasemi, Y., Savardashtaki, A., & Mirzaei, H. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666191001113511 · Cited by 60

Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer

Chen, Z., Yuan, Y.-C., Wang, Y., Liu, Z., Chan, H. J., & Chen, S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3446-8 · Cited by 59

MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2

Ho, C., Bar, E. E., Giannini, C., Marchionni, L., Karajannis, M. A., Zagzag, D., Gutmann, D. H., Eberhart, C. G., & Rodriguez, F. J. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos269 · Cited by 59

The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets

Weidle, U. H., Dickopf, S., Hintermair, C., Kollmorgen, G., Birzele, F., & Brinkmann, U. (2018) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20062 · Cited by 57

MicroRNA-21, up-regulated by arsenite, directs the epithelial–mesenchymal transition and enhances the invasive potential of transformed human bronchial epithelial cells by targeting PDCD4

Luo, F., Ji, J., Liu, Y., Xu, Y., Zheng, G., Jing, J., Wang, B., Xu, W., Shi, L., Lü, X., et al. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.11.001 · Cited by 56

MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-β pathways

Han, M., Wang, F., Gu, Y., Pei, X., Guo, G., Yu, C., Li, L., Zhu, M., Xiong, Y., & Wang, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.4360 · Cited by 54

TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion

Chevalier, C., Collin, G., Descamps, S., Touaitahuata, H., Simon, V., Reymond, N., Fernandez, L., Milhiet, P., Georget, V., Urbach, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms10765 · Cited by 53

MicroRNAs and lung cancers: from pathogenesis to clinical implications

Qi, J., & Mu, D. (2012) · Frontiers of Medicine · doi:10.1007/s11684-012-0188-4 · Cited by 52

Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks.

Gomez, G. G., Wykosky, J., Zanca, C., Furnari, F. B., & Cavenee, W. K. (2013) · Europe PMC (PubMed Central) · doi:10.7497/j.issn.2095-3941.2013.04.003 · Cited by 53

Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival

Young, J. S., Kawaguchi, T., Yan, L., Qi, Q., Liu, S., & Takabe, K. (2017) · Oncotarget · doi:10.18632/oncotarget.21577 · Cited by 51

A comprehensive review on oncogenic miRNAs in breast cancer

Nurzadeh, M., Naemi, M., & Hasani, S. S. (2021) · Journal of Genetics · doi:10.1007/s12041-021-01265-7 · Cited by 51

MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway

Liu, F., Zheng, S., Liu, T., Liu, Q., Liang, M., Li, X., Sheyhidin, I., Lu, X., & Liu, W. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1693-8 · Cited by 46

Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease

Mehrgou, A., & Akouchekian, M. (2017) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_967_16 · Cited by 46

Deltex-1 Activates Mitotic Signaling and Proliferation and Increases the Clonogenic and Invasive Potential of U373 and LN18 Glioblastoma Cells and Correlates with Patient Survival

Huber, R. M., Rajski, M., Sivasankaran, B., Moncayo, G. E., Hemmings, B. A., & Merlo, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057793 · Cited by 44

MicroRNA Cancer Regulation

Schmitz, U., Wolkenhauer, O., & Vera, J. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-5590-1 · Cited by 56

MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2

Zhu, D., Gu, L., Li, Z., Jin, W., Lu, Q., & Ren, T. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.01.029 · Cited by 45

MicroRNA-gene signaling pathways in pancreatic cancer

Iliopoulos, D., & Drakaki, A. (2013) · Biomedical Journal · doi:10.4103/2319-4170.119690 · Cited by 44

Engagement of Overexpressed Her2 with GEP100 Induces Autonomous Invasive Activities and Provides a Biomarker for Metastases of Lung Adenocarcinoma

Menju, T., Hashimoto, S., Hashimoto, A., Otsuka, Y., Handa, H., Ogawa, E., Toda, Y., Wada, H., Date, H., & Sabe, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025301 · Cited by 44

Potentially predictive microRNAs of gastric cancer with metastasis to lymph node

Wu, W. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i31.3645 · Cited by 44

Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism

Beltrán‐Anaya, F. O., Cedro‐Tanda, A., Hidalgo‐Miranda, A., & Romero-Cordoba, S. L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00342 · Cited by 44

Urtica dioica extract suppresses miR-21 and metastasis-related genes in breast cancer

Mansoori, B., Mohammadi, A., Hashemzadeh, S., Shirjang, S., Baradaran, A., Asadi, M., Doustvandi, M. A., & Baradaran, B. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.021 · Cited by 43

Small molecule with big role: MicroRNAs in cancer metastatic microenvironments

Su, Y., Li, X., Ji, W., Sun, B., Xu, C., Li, Z., Qian, G., & Su, C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.10.024 · Cited by 42

Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options

McAnena, P. F., McGuire, A., Ramli, A., Curran, C. E., Malone, C., McLaughlin, R. A., Barry, K., Brown, J. A. L., & Kerin, M. J. (2018) · BMC Cancer · doi:10.1186/s12885-018-4101-7 · Cited by 42

The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers

Wilmott, J. S., Zhang, X. D., Hersey, P., & Scolyer, R. A. (2011) · Pathology · doi:10.1097/pat.0b013e32834a7358 · Cited by 41

MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome

Medimegh, I., Omrane, I., Privat, M., Uhrhummer, N., Ayari, H., Belaiba, F., Benayed, F., Benromdhan, K., Mader, S., Bignon, I.-J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111877 · Cited by 41

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., & Mo, Y.-Y. (2008) · Cell Research · doi:10.1038/cr.2008.24 · Cited by 1,051

MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression

Song, B., Wang, C., Liu, J., Wang, X., Lv, L., Wei, L., Xie, L., Zheng, Y., & Song, X. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-29 · Cited by 249

Exploration of the regulatory effect of miR-21 on breast cancer cell line proliferation and invasion as well as the downstream target genes

Kuang, Y., & Nie, Y. (2016) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.03.025 · Cited by 18

Expression of miR-145 in breast cancer and its role in invasion and migration of breast cancer cells

Wang, H., Liu, S., Wu, T., Wang, J., Li, X., Chen, W., Lu, H., & Kong, Q. (2015) · Zhonghua jianyan yixue zazhi · doi:10.3760/cma.j.issn.1009-9158.2015.03.011 · Cited by 1

P3-03-04: Targeted Modulation of HER Receptor Signaling in Breast Cancer Using miR-21.

Aubele, M. M., Ludyga, N., Braselmann, H., Atkinson, M., Auer, G., & Anastasov, N. (2011) · Cancer Research · doi:10.1158/0008-5472.sabcs11-p3-03-04